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COMPARISON OF DURATION OF ACTIVITY OF REGULAR AND
PROLONGED ACTING PRO-BANTHINE MEASURED BY THE
GALVANIC SKIN RESPONSE*
DANIEL J. PERRY, M.D.t AND GEORGE E. MOUNT, PILD.t
Previous studies (1, 2, 3) indicate that sweat
stimulating and sweat inhibiting drugs have a
measurable effect on the Galvanic Skin Response
(GSR). Recently this technic was used to compare
dose-response curves of orally and intramus-
cularly administered compounds (4, 5). These
results suggested the possibility of adapting the
GSR to follow the duration of action of drugs.
Therefore, such an investigation was undertaken
with regular and a prolonged acting form of
ProBanthinc®.
MATRRIAL5 AND METHODS
Ten male subjects (22—36 years of age) were
tested separately to a placebo, 120 mg. regular
Pro-Banthine and 120 mg. prolonged acting
Pro-Banthine administered orally in a varying
order. In each experiment an initial 5 minute
recording of the GSR level was made 1 3—2
hours after breakfast. Similar 5 minute records
were made subsequently at hourly intervals for
7 hours. Two or more days elapsed between
drugs for eight subjects. There was a one day
interval between the regular and prolonged
acting Pro-Banthine for one subject and in
another the drugs were administered on succes-
sive days. All experiments were performed by
the same investigator in the same room.
The method of handling the data in the present
experiments differs from previous studies. In the
latter the GSR level was recorded continuously
for 45—60 minutes and the unit of measurement
was obtained by averaging the high and low
resistance levels for each 3i minutes of record.
In the present series the GSR level was recorded
for five minute periods at the time of drug
FIG. 1
administration and subsequently at hourly
intervals for seven hours. In the interim between
measurements each subject was physically active
so the GSR level in the beginning of a measure-
ment tends to be higher than at the end of the
five minute period when the subject has been
sitting quietly. Therefore the resistance level
uniformly selected in all tests was the minimum
GSR level in each five Ininute period. These
values were then converted into the unit micro-
mhosUl (3), averaged for each test period and
plotted in Figure 1. One measurement was
missing at the 1st, 2nd and 7th hours in a placebo
test and at the 3rd hour for each of the drugs.
The effect of this was to reduce the number of
measures at these positions to nine. Separate
calibrations made at the beginning and end of
each five minute recording were used as a basis
for individual resistance readings.
RESULTS
In Figure 1 all initial levels were adjusted to
the same point as previously described (4). The
placebo curve follows a fairly flat pattern with
transient deviations from the initial level through-
out the experiment. Both regular and prolonged
Pro-Banthine show a sustained fall in GSR level
(decreased sweating) reaching its low point about
three hours after administration. Then the
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regular Pro-Banthine curve begins to rise while
the prolonged Pro-Banthine curve tends to
follow a lower level for the remaining four hours
of the test. Both prolonged and regular drugs
maintain a lower GSR level than the placebo for
the entire experiment.
DISCUSSION
The difference between both types of Pro-
Banthine and placebo shown in Figure 1 is
statistically significant beyond the one per cent
level in the period 2—5 hours after administration.
This deviation of anticholinergic compounds and
placebo has been recorded in other experiments
(1—5) and the present observations furnish
additional verification. Regular and prolonged
Pro-Banthine are not significantly different.
However the trend is for the regular Pro-Ban-
thine curve to rise from its low point in three
hours and approach the placebo curve. This
suggests that the anticholineric effect is begin-
ning to diminish. The prolonged Pro-Banthine
curve tends to remain at a lower level and does
not demonstrate the rise in the 5th and 6th hours
illustrated by regular Pro-Banthine. Since the
differences between the two drugs in the last two
hours of the experiments is not statistically
significant we can only generalize that the pattern
obtained suggests that the curves of the two
compounds tend to separate. It also appears
that if the experiments had been pursued for a
longer period, the regular Pro-Banthine would
have lost its anticholinergic effect before the
prolonged acting compound. An interesting
observation resulting from the present experi-
ments is that regular Pro-Banthine maintains
some anticholinergic effect seven hours after
administration. This is most likely a function of
the large dose administered (120 mg.). However,
the possibility of a prolonged effect of regular
Pro-Banthine cannot be ruled out until additional
studies are made with smaller quantities. Similar
tests for a longer period of time, if possible,
should also be made with prolonged Pro-Ban-
thine. Such a study will clarify the question of
the significance of the difference observed in seven
hours in the present experiments.
SUMMAJIv
The Galvanic Skin Response has been used as
a measure of the duration of activity of regular
and prolonged acting Pro-Banthine. Both drugs
show a significant difference from the placebo as
previously demonstrated. Regular Pro-Banthine
appears to lose its anticholinergic effect before
the prolonged drug. However, this difference is
not statistically significant under the present
experimental conditions.
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